United States of America
Dr. Hoffman is a human molecular geneticist with expertise in clinical trials and drug development in Duchenne muscular dystrophy and other neuromuscular disorders. He is Professor and Associate Dean at Binghamton University – State University of New York in the School of Pharmacy and Pharmaceutical Sciences. He has co-founded ReveraGen, TRiNDS, and AGADA Biosciences.
Eric holds the following positions:
ReveraGen BioPharma. Co-founder, share holder, VP Research.
TRiNDS LLC. Co-founder, share holder, Board member.
AGADA Biosciences. Co-founder, share holder, CEO.